On Tuesday shares of Brixmor Property Group Inc. (NYSE:BRX) closed at $26.37. Company’s sales growth for last 5 years was 1.20% and EPS growth for next 5 years is recorded as 15.90%. Brixmor Property Group Inc. (NYSE:BRX) announced that certain selling stockholders (the “Selling Stockholders”) affiliated with Blackstone Real Estate Partners have commenced a secondary offering of 22,500,000 shares of Brixmor’s common stock. The underwriters will have a 30-day option from the date of the offering to purchase up to an additional 3,375,000 shares of common stock from the Selling Stockholders.
DDR Corp. (NYSE:DDR) in last trading activity moved down -1.20% to close at $18.87. Company weekly performance is 1.94% while its quarterly performance stands at 4.02%. DDR Corp. (NYSE:DDR) is -7.50% away from its 52 week high. Research analysts at Citigroup Inc. boosted their price target on shares of DDR Corp (NYSE:DDR) from $19.00 to $20.00 in a report released on Friday. The firm currently has a “neutral” rating on the stock. Citigroup Inc.’s target price would indicate a potential upside of 3.47% from the stock’s previous close.
On last trading day XOMA Corporation (NASDAQ:XOMA) moved down -2.01% to close at $3.90. Its volatility for the week is 6.56% while volatility for the month is 6.44%. XOMA’s sales growth for past 5 years was -28.10% and its EPS growth for past 5 years was -55.90%. XOMA Corporation (NASDAQ:XOMA) monthly performance is -5.11%. On March 11, XOMA Corporation (NASDAQ:XOMA) reported a loss of 12 cents per share in the fourth quarter of 2014, much narrower than the year-ago loss of 55 cents per share. Revenues for the reported quarter came in at $4.3 million, significantly lower than the year-ago revenues of $12.5 million and the Zacks Consensus Estimate of $9 million.
Shanda Games Limited (NASDAQ:GAME) has 14.14% insider ownership while its institutional ownership stands at 12.90%. In last trading activity company’s stock closed at $6.51. On March 16, Shanda Games Limited (NASDAQ:GAME) said it has been informed by Ningxia Yilida Capital Investment Limited Partnership, a limited partnership organized under the laws of the People’s Republic of China and an affiliate of the Company’s acting CEO, Yingfeng Zhang, and Ningxia Zhongyincashmere International Group Co., Ltd., that Ningxia Yilida, Ningxia, Orient Hongtai (Hong Kong) Limited, Orient Hongzhi (Hong Kong) Limited, and Hao Ding International Limited entered into a consortium agreement on March 16, 2015, by which they agreed to form a consortium to acquire the Company in a “going private” transaction.
On last trading day BioTelemetry, Inc. (NASDAQ:BEAT) moved down -1.46% to close at $10.15. Its volatility for the week is 3.68% while volatility for the month is 4.14%. BEAT’s sales growth for past 5 years was 3.50% and its EPS growth for past 5 years was 15.50%. BioTelemetry, Inc. (NASDAQ:BEAT) monthly performance is 6.28%. On March 19, it was reported that, BioTelemetry, Inc. (NASDAQ:BEAT), has agreed to pay $6.4 million to resolve allegations made under the False Claims Act (FCA) that its subsidiary, CardioNet, overbilled Medicare and other federal health programs for Mobile Cardiac Outpatient Telemetry (MCOT) services when those services were not reasonable or medically necessary.